KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Common Equity (2016 - 2026)

National Health Investors filings provide 18 years of Common Equity readings, the most recent being $1.5 billion for Q1 2026.

  • On a quarterly basis, Common Equity rose 5.56% to $1.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 billion, a 5.56% increase, with the full-year FY2025 number at $1.5 billion, up 11.22% from a year prior.
  • Common Equity hit $1.5 billion in Q1 2026 for National Health Investors, down from $1.5 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.5 billion in Q4 2025 to a low of $1.2 billion in Q3 2024.
  • Median Common Equity over the past 5 years was $1.3 billion (2022), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Common Equity: decreased 15.62% in 2022 and later increased 20.27% in 2025.
  • National Health Investors' Common Equity stood at $1.3 billion in 2022, then dropped by 1.23% to $1.3 billion in 2023, then increased by 8.78% to $1.4 billion in 2024, then increased by 11.22% to $1.5 billion in 2025, then decreased by 0.98% to $1.5 billion in 2026.
  • The last three reported values for Common Equity were $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025) per Business Quant data.